It is not possible to assess the safety of HPV vaccines due to a lack of transparency
By Rhoda Wilson on October 15, 2025

Due to the lack of transparency from manufacturers like GSK and Merck, there is concern about the safety of the HPV vaccines. 

In a recent article, the HART Group reviews the evidence and highlights the known risks, acknowledged and unacknowledged uncertainties about the vaccine’s safety and the unknown risks of the vaccine from available data.

HPV Vaccine Safety
By HART Group

As with all medicines, the best evidence for safety will be from properly controlled randomised clinical trials with sufficient follow-up time. For vaccines in an otherwise healthy population, such trials need to be large and long and would not fit with the pharmaceutical business model. Regulators, therefore, become responsible for safety monitoring but do not put systems in place to ensure a fair control group to enable proper measurement. The consequences are that safety issues of a variety of types occur.

more:

https://expose-news.com/2025/10/15/safety-of-hpv-vaccines/